Clinical Trials Logo

Neurofibromatosis 1, NF1 clinical trials

View clinical trials related to Neurofibromatosis 1, NF1.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02479360 Completed - Clinical trials for Neurofibromatosis 1, NF1

Reliability of Functional Outcome Measures in Neurofibromatosis 1

Start date: June 2015
Phase: N/A
Study type: Observational

Neurofibromatosis 1 (NF1) is a common inherited condition that affects the skin, bone and nervous system. The complications of NF1 are widespread and can lead to varied difficulties dependent on the location of neurofibromas and their secondary complications. At present evaluation of the effect of treatments in NF1 is based on a clinician's neurological assessment, magnetic resonance imaging and positron emission tomography but it is apparent that imaging results do not always link with clinical and functional changes in an individual. This study aims to evaluate the reliability (stability) of a range of functional standardised outcome measures in adults with NF1.